Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
The Environmental Justice Lab
Lesley Joseph
TheThinkingAtheist
The Thinking Atheist
Rachel Lawson's The Magicians Podcast
Rachel Lawson
AI News Podcast | Latest AI News, Analysis & Events | Daily Inference
AI Daily
That UFO Podcast
That UFO Podcast
Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc!
Byte & Pieces
Astronomy Daily: Space News Updates
bitesz.com
DayWeather Podcast
DayWeather
Small Nonprofit: Fundraising Tips, Leadership Strategies, and Community-Centric Solutions
Further Together: Fundraising Strategies for Nonprofit Organizations
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Emergence Magazine Podcast
Emergence Magazine
Welcome to Florida
Chadd Scott
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Cotton Specialists Corner
Extension Cotton Specialists
Los Angeles Weather Daily
Fast Foundations
Phoenix Weather Daily
Fast Foundations
Fins, Fur, and Feathers
Joe Gerken and Drew Ricketts
San Diego Weather Daily
Fast Foundations
Psychotherapy and Applied Psychology
Dr. Daniel W Cox
San Francisco Weather Daily
Fast Foundations
Animals, Nature, and You
Rick Schwartz
The Pools Scientific Podcast
John Cooper
The Poultry Podcast Show
Wisenetix
Artificial Intelligence Masterclass
AI Masterclass
Quazi Johir
Quazi Johir
The Dirt on Gardening
Andre Baptiste, Graylen Brown, Derek Haynes
Stuck Not Broken
Justin Sunseri
The Parkinson's Podcast
Davis Phinney Foundation
Biophilic Solutions: Nature Has the Answers
Serenbe Media Network
What it Means To Be Human
Dan Zetterstrom / Double Barrel
The Global Grit Experience
Erika Gilsdorf
Are We Doomed?
NPR Network
Huberman Lab
Huberman Lab
Astronomie : Fragments d'Univers
Astronomie : Fragments d'Univers
Dateable: Your insider's look into modern dating and relationships
Yue Xu and Julie Krafchick
A Better Way To Farm Podcast
Rod Livesay
Science
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
What if the simple act of opening an incubator could undermine the consistency of your cell therapy manufacturing process? Unlike traditional biologics, the moment cells leave their incubator, subtle shifts in temperatur...
Digital transformation in biotech is no longer just about adopting new tools, it's about building a foundation where automation, data standardization, and AI integration actually lead to real value and long-term success....
Despite cutting-edge equipment and brilliant minds, biotech labs often find half their data trapped in difficult-to-access spreadsheets or isolated in silos, making true digital transformation a major, industry-wide hurd...
Host David Brühlmann returns for a focused solo episode to provide an honest, data-driven perspective on the evolving landscape of host selection for biologics manufacturing. Building on part one, David reviews five alte...
In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous dat...
Funding novel therapeutics isn’t just “harder than ever”—the rules have changed entirely. The wild rush of capital into early-stage biotech during 2020–2021 gave way to a drought, making investor priorities sharper and s...
Strong science alone won’t get your biotech startup funded—investors are sizing up much more than just your molecule.Michael Rome, who leads therapeutics investing at Foresite Capital, brings a rare dual lens as both sci...
What happens between scientific discovery and clinical trials? For too many drug candidates, the answer is “failure”—not because the idea lacked merit, but because the critical handoff between discovery and IND-enabling ...
The gap between a “drug” and a true “product” is where many therapies fail.Milan Tomic, biotech veteran, GMP manufacturing expert, and founder of Albrem, has spent 30 years turning promising science into scalable, execut...
The "data lake" that was supposed to unify bioprocessing intelligence has, in most companies, become something else entirely: a data swamp, where information goes in and insight rarely comes back out. For anyone trying t...
When AI can draft a literature review in minutes, the question bioprocess educators can no longer avoid is this: what does a student actually need to learn?Steffen Kreye has a clear answer. As Professor of Industrial Bio...
Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells?In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biol...
What if the key to scalable, off-the-shelf cell therapy was hiding in tissue that surgeons discard every day?Yuta Lee, Founder and CEO of Accelerated Bio, has spent two decades building a cell therapy platform on exactly...
Are you still using one-factor-at-a-time experiments for biosimilar development, losing months, missing interactions, and risking costly dead-ends?In this episode, David Brühlmann, host of the Smart Biotech Scientist Pod...
Are you stuck screening endless compounds in biosimilar development and still not hitting your quality targets? Efficient compound screening is one of the toughest bottlenecks in biopharma, with outdated methods slowing ...
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from process development into the broader consequences of that reality: the manufac...
The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the patient. Chantale Bernatchez has spent 20 years learning that lesson the ...
Getting an NDA signed shouldn't take weeks. If your CRO needs more than 48 hours to start the paperwork, your project timeline is already moving in the wrong direction.Ron Najafi knows what rigorous analytical work actua...
When drug safety fails, patients and entire markets pay the price. Understanding your CMC isn't just compliance — it's the line between therapeutic promise and product recall.Ron Najafi has lived that reality firsthand. ...
Shear sensitivity is the silent challenge behind many advanced biomanufacturing modalities. Orbital-shaken bioreactors—often underestimated—may be a key enabler your CMC development is missing.Tibor Anderlei, CSO at Kühn...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.